15 years' experience with hyperthermic perfusion for treatment of soft tissue sarcoma and malignant melanoma of the extremities.
D000671:Amputation, Surgical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003609:Dactinomycin / Q000008:administration & dosage; D005121:Extremities; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects; D007275:Injections, Intravenous; D008545:Melanoma / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D008558:Melphalan / Q000008:administration & dosage; D010477:Perfusion; D012509:Sarcoma / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*
D003609:Dactinomycin; D008558:Melphalan